Author Topic: (AAN) Biogen says new MS drug Vumerity (diroximel fumarate, BIIB098) under FDA review  (Read 19 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8282
  • MS diagnosed 1980
  • Location: Pacific Northwest
Neurofilament light chains received quite a bit of attention at the annual AAN conference for 2019 (Philadelphia, May 4-10). They're mentioned in this article from Multiple Sclerosis News Today (May 15, 2019) entitled "Biogen Offers Update on Development Plans for MS Therapies." The Biogen spokesperson is announcing another new MS drug, Vumerity, which is up for FDA review:


http://bit.ly/2vZW9t9
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
53 Views
Last post May 29, 2016, 04:39:51 pm
by agate
0 Replies
99 Views
Last post August 11, 2016, 09:54:08 am
by agate
0 Replies
37 Views
Last post July 21, 2017, 03:21:38 pm
by agate
0 Replies
5 Views
Last post October 29, 2019, 07:28:38 pm
by agate
0 Replies
4 Views
Last post October 31, 2019, 08:49:09 am
by agate